VitaNova develops and sells dietary supplements and functional nutrition products. VitaNova operates through its subsidiary NutriPeak Trading and manages two main brands. GeneCode offers formulations focused on cellular health and cognitive wellness, while AMZ provides mass-market nutrition products for metabolic and digestive health. VitaNova uses an asset-light business model. VitaNova handles product formulation, brand management, and regulatory compliance internally while outsourcing manufacturing, packaging, and fulfillment to third-party contract manufacturers. VitaNova sells products primarily through a B2B model, partnering with regional distributors who use online platforms such as Douyin Cross-border, Weidian Cross-border, and direct-to-consumer channels. VitaNova also uses social media and influencer collaborations to market products. In addition to the supplement business, VitaNova operates a consulting segment providing business-advisory services and a healthy food trading business through VitaNova Global Foods. The food trading segment distributes products like olive juice and sesame oil to generate cash flow for broader operations. Expenses from contract manufacturers and logistics partners drive VitaNova's cost structure. VitaNova plans to expand its business model by launching a subscription platform designed to generate recurring revenue.
Read full business overview →Mid to long-term bullish thesis
View →Mid to long-term bearish thesis
View →Mid to long-term bull-bear debate
View → NEWSummary and scoring of the bull-bear debate
View →Find ideas with similar bull or bear theses
View →Investor-relevant company attributes
View →Key risks to the business
View →Comparisons of annual risk disclosures
View →